Bioventix (LON:BVXP) Shares Cross Below 200 Day Moving Average – What’s Next?

Bioventix PLC (LON:BVXP)’s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2,559.57 and traded as low as GBX 2,175. Bioventix shares last traded at GBX 2,200, with a volume of 14,916 shares traded.

Bioventix Stock Performance

The company has a market cap of £113.64 million, a price-to-earnings ratio of 15.18 and a beta of 0.35. The business has a fifty day moving average price of GBX 2,333.62 and a 200 day moving average price of GBX 2,559.57.

Bioventix (LON:BVXP) last released its quarterly earnings data on Monday, October 27th. The biotechnology company reported GBX 145.27 earnings per share for the quarter. Bioventix had a return on equity of 69.09% and a net margin of 59.51%. As a group, equities analysts anticipate that Bioventix PLC will post 166.3066955 EPS for the current year.

Insider Activity

In related news, insider Peter John Harrison acquired 875 shares of the company’s stock in a transaction that occurred on Tuesday, November 4th. The stock was acquired at an average price of GBX 2,220 per share, with a total value of £19,425. Also, insider Bruce Hiscock bought 119 shares of the business’s stock in a transaction on Monday, October 27th. The stock was bought at an average price of GBX 2,009 per share, for a total transaction of £2,390.71. In the last three months, insiders have purchased 1,494 shares of company stock worth $3,114,071. Corporate insiders own 6.02% of the company’s stock.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.